Subscribe

Nautilus Biotechnolgy, Inc. (NAUT)

USD1.75 -0.01 (-0.29%)
US NASDAQ Healthcare Biotechnology
Address 2701 Eastlake Avenue East 98102
Seattle, WA, US
CEO Sujal Patel
IPO 2020-08-07
CIK 1808805 ISIN US63909J1088

Explore sections of this company profile

Description

Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome in the United States. The company develops Nautilus Voyager Platform, which includes an end-to-end solution comprising instruments, reagents, consumables, and software analysis. It also provides nautilus voyager instrument, a high-resolution optical imaging system with integrated fluidics and liquid handling sub-system to deposit protein libraries onto a flow cell and to process labeled multi-affinity reagent binding and imaging cycles rapidly to decode and quantify the proteins present in biological samples. In addition, the company offers single-molecule library preparation kits, flow cells, affinity reagents, and instrument run buffers to perform multi-cycle analysis runs. It has a research collaboration agreement Genentech, Buck Institute, Allen Institute, Cornell University and the Qatar Foundation, and Michael J. Fox Foundation. Nautilus Biotechnology, Inc. was founded in 2016 and is headquartered in Seattle, Washington.

News Sentiment (7d)
59 Neutral

Based on only 1 article — low confidence

Market Cap & Enterprise Value
Merger & Acquisition History
Target company Ticker Date Filing
Rule ARYA 2021-03-26 View
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
USD1.75 -0.01 (-0.29%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
529.6K
Beta
0.75
Float Shares
47.22M
Free Float %
37.2%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
+5.38% +7.87% +4.18% +13.22% +21.78% +40.51% +274.42% -4.20% -73.14% -73.75% -73.75%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Analyst Consensus (5 ratings, all time) Buy
Price Targets & DCF
Current price
1.75
Low 2.50 +43.3%
Consensus 2.50 +43.3%
Median 2.50 +43.3%
High 2.50 +43.3%
Ratings Trend (MoM) 100% Bullish
Rating 2026-05 Change
Strong Buy 0 0
Buy 2 0
Hold 0 0
Sell 0 0
Strong Sell 0 0
Price Target Summary
Period # Analysts Avg Target
Last Month
Last Quarter
Last Year
All Time 2
4.25
+143.6%
Quality scores
Altman Z-Score
2.98
Grey zone
Piotroski F-Score
1 / 9
Weak
MOAT Score
3 / 10
No MOAT
Composite Rating
C-
Overall Score
1 / 5
Low
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
2 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
2 / 5
Medium
Operational MOAT
✗ Below peers
  • Revenue growth Biotechnology: +1.6%
  • EPS growth Biotechnology: +29.7%
    +16.1% Q1'26: +7.7% (vs Q1'25)
  • FCF margin FCF growth · Biotechnology: +16.2%
  • EBIT margin Biotechnology: +0.0%
  • ROIC Biotechnology: -16.1%
    -70.6% Q1'26: -83.3% (vs Q1'25)
  • Share dilution Biotechnology: -3.4%
    +0.7% Q1'26: +0.4% (vs Q1'25)
  • Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×
    -0.57× Q1'26: -0.49× (vs Q1'25)
Valuation Multiples From To
DCF Interactive Model (UFCF)
Projection years:
Market assumptions
WACC components (optional)
Ke (Cost of Equity) = Rf + β (0.75) × ERP
WACC = 92% × Ke + 8% × Kd (4.1%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
Current price: 1.75
Enterprise Value: Equity Value: Terminal Value: TV as % of EV:

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Dec 2024
actual
Dec 2025
actual
Dec 2026
2 Rev. Ana.
2 EPS Ana.
Dec 2027
2 Rev. Ana.
2 EPS Ana.
Dec 2028
1 Rev. Ana.
1 EPS Ana.
Dec 2029
1 Rev. Ana.
1 EPS Ana.
Dec 2030
1 Rev. Ana.
1 EPS Ana.
Revenue
est: 122.6K (-100.0%)
est: 1.79M (-100.0%)
700.0K
500.0K – 900.0K
-60.9% YoY
7.65M
4.80M – 10.50M
+992.9% YoY
30.00M
19.04M – 40.96M
+292.2% YoY
68.70M
43.61M – 93.79M
+129.0% YoY
126.70M
80.42M – 172.98M
+84.4% YoY
EBITDA
-64.43M
-52.54M
— – —
— – —
— – —
— – —
— – —
EBIT
-70.78M
-59.00M
— – —
— – —
— – —
— – —
— – —
Net Income
-70.78M
est: -65.69M (-7.8%)
-59.00M
est: -66.28M (+11.0%)
-65.02M
-65.65M – -64.39M
+1.9% YoY
-65.65M
-77.02M – -54.29M
-1.0% YoY
-54.29M
-80.07M – -28.51M
+17.3% YoY
-46.71M
-68.90M – -24.53M
+14.0% YoY
-30.30M
-44.69M – -15.91M
+35.1% YoY
SGA
31.00M
25.73M
— – —
— – —
— – —
— – —
— – —
EPS
-0.56
est: -0.45 (-23.8%)
-0.47
est: -0.53 (+10.5%)
-0.52
-0.52 – -0.51
+1.9% YoY
-0.52
-0.61 – -0.43
-1.0% YoY
-0.43
-0.63 – -0.23
+17.3% YoY
-0.37
-0.55 – -0.19
+14.0% YoY
-0.24
-0.35 – -0.13
+35.1% YoY
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-28 C- 1/5 1/5 1/5 1/5 2/5 1/5 2/5
2026-05-27 C- 1/5 1/5 1/5 1/5 2/5 1/5 2/5
2026-05-26 C- 1/5 1/5 1/5 1/5 2/5 1/5 2/5
2026-05-22 C- 1/5 1/5 1/5 1/5 2/5 1/5 2/5
2026-05-21 C- 1/5 1/5 1/5 1/5 2/5 1/5 2/5
2026-05-20 C- 1/5 1/5 1/5 1/5 2/5 1/5 2/5
2026-05-19 C- 1/5 1/5 1/5 1/5 2/5 1/5 2/5
2026-05-18 C- 1/5 1/5 1/5 1/5 2/5 1/5 2/5
2026-05-15 C- 1/5 1/5 1/5 1/5 2/5 1/5 2/5
2026-05-14 C- 1/5 1/5 1/5 1/5 2/5 1/5 2/5
2026-05-13 C- 1/5 1/5 1/5 1/5 2/5 1/5 2/5
2026-05-12 C- 1/5 1/5 1/5 1/5 2/5 1/5 2/5
2026-05-11 C- 1/5 1/5 1/5 1/5 2/5 1/5 2/5
2026-05-08 C- 1/5 1/5 1/5 1/5 2/5 1/5 2/5
2026-05-07 C- 1/5 1/5 1/5 1/5 2/5 1/5 2/5
2026-05-06 C- 1/5 1/5 1/5 1/5 2/5 1/5 2/5
2026-05-05 C- 1/5 1/5 1/5 1/5 2/5 1/5 2/5
2026-05-04 C- 1/5 1/5 1/5 1/5 2/5 1/5 2/5
2026-05-01 C- 1/5 1/5 1/5 1/5 2/5 1/5 2/5
2026-04-30 C- 1/5 1/5 1/5 1/5 2/5 1/5 2/5
2026-04-29 C- 1/5 1/5 1/5 1/5 2/5 1/5 2/5
2026-04-28 C- 1/5 1/5 1/5 1/5 2/5 1/5 2/5
2026-04-27 C 2/5 1/5 1/5 1/5 2/5 1/5 4/5
2026-04-24 C 2/5 1/5 1/5 1/5 2/5 1/5 4/5
2026-04-23 C 2/5 1/5 1/5 1/5 2/5 1/5 4/5
2026-04-22 C 2/5 1/5 1/5 1/5 2/5 1/5 4/5
2026-04-21 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-04-20 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-04-17 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-04-16 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5

Owner Earnings

Owner's Earnings (history)

Owner's Earnings history not available.

Owner alignment
Owner's Earnings TTM
OE per share TTM
Owner's Yield
Maintenance CapEx ratio
Maint CapEx / Avg PPE

Ownership Overview

Ownership breakdown
At a glance
Institutional holders
81
Total invested
210.83M
Insider transactions (90d)
0
Beneficial owners (>5%)
27
Beneficial owners (>5%)
# Reporting person Amount owned % of class Sole voting Shared voting Sole dispositive Shared dispositive Type Citizenship Filing date SEC filing
1 Parag Mallick 21.15M 17.00% 21.15M 21.15M 10.00 IN USA 2021-06-16
2 Benjamin Horowitz (“Horowitz”) 17.65M 14.20% 17.65M 10.00 IN OR PLACE OF ORGANIZATION 2021-06-30
3 Marc Andreessen (“Andreessen”) 17.65M 14.20% 17.65M 10.00 IN OR PLACE OF ORGANIZATION 2021-06-30
4 Sujal Patel 17.50M 14.00% 15.68M 1.81M 15.68M 10.00 IN USA 2021-06-16
5 AH Equity Partners Bio II, L.L.C. (“AH Equity Bio II”) 16.30M 13.10% 16.30M 16.30M 10.00 OO OR PLACE OF ORGANIZATION 2021-06-30
6 AH Bio Fund II, L.P. (“AH Bio II”) 16.01M 12.90% 16.01M 16.01M 10.00 PN OR PLACE OF ORGANIZATION 2021-06-30
7 Joseph Edelman 8.91M 7.20% 8.91M 8.91M IN 2021-06-21
8 Perceptive Advisors LLC 8.91M 7.20% 8.91M 8.91M IA 2021-06-21
9 Perceptive Life Sciences Master Fund, Ltd. 8.91M 7.20% 8.91M 8.91M CO 2021-06-21
10 Cercano Management LLC 7.17M 5.80% 7.17M IA Delaware 2023-02-13
11 Christopher N. Orndorff 7.17M 5.80% 7.17M IN Delaware 2023-02-13
12 Cougar Investment Holdings LLC 7.17M 5.80% 7.17M 7.17M OO Delaware, U.S.A. 2022-02-10
13 ARYA Sciences Holdings III 4.15M 3.30% 4.15M 4.15M CO Cayman Islands 2021-06-14
14 Adam Stone 4.15M 3.30% 4.15M 4.15M IN Cayman Islands 2021-06-14
15 Michael Altman 4.15M 3.30% 4.15M 4.15M IN Cayman Islands 2021-06-14
16 VCVC Management V LLC 3.59M 2.90% 3.59M 3.59M OO Delaware, U.S.A. 2022-02-10
17 VCVC V LLC 3.59M 2.90% 3.59M 3.59M OO Delaware, U.S.A. 2022-02-10
18 VC Capital Holdings Columbia LLC 3.59M 2.90% 3.59M 3.59M OO Delaware, U.S.A. 2022-02-10
19 VCHC Management LLC 3.59M 2.90% 3.59M 3.59M OO Delaware, U.S.A. 2022-02-10
20 RA Capital Management, L.P. 2.44M 2.00% 2.44M 2.44M IA, PN United States America 2022-02-14
21 AH Equity Partners LSV II, L.L.C. (“AH Equity LSV II”) 1.36M 1.10% 1.36M 1.36M 10.00 OO OR PLACE OF ORGANIZATION 2021-06-30
22 Andreessen Horowitz LSV Fund II, L.P. (“AH LSV II”) 1.21M 1.00% 1.21M 1.21M 10.00 PN OR PLACE OF ORGANIZATION 2021-06-30
23 Bain Capital Life Sciences Fund II, L.P. 891.4K 5.80% 891.4K 891.4K PN Cayman Islands 2020-08-13
24 AH Bio Fund II-B, L.P. (“AH Bio II-B”) 289.6K 0.20% 289.6K 289.6K 10.00 PN OR PLACE OF ORGANIZATION 2021-06-30
25 Andreessen Horowitz LSV Fund II-Q, L.P. (“AH LSV II-Q”) 120.8K 0.10% 120.8K 120.8K 10.00 PN OR PLACE OF ORGANIZATION 2021-06-30
26 BCIP Life Sciences Associates, LP 108.6K 0.70% 108.6K 108.6K PN Cayman Islands 2020-08-13
27 Andreessen Horowitz LSV Fund II-B, L.P. (“AH LSV II-B”) 27.0K 0.10% 27.0K 27.0K 10.00 PN OR PLACE OF ORGANIZATION 2021-06-30

Institutional Activity (13F)

Institutional ownership trend From To
13F snapshot — 2026 Q1
Investors holding
81
+15 vs prev Q
New positions
27
Closed positions
12
Increased
44
Reduced
13
Put/Call ratio
0.00
Calls held
61.7K
Puts held
Top institutional holders
# Investor Shares / Δ Mkt value / Δ Own% / Δ Weight% / Δ Avg px / Perf. Hold / Status
1 AH CAPITAL MANAGEMENT, L.L.C. 17.65M +— (+0.0%) 34.43M +19.5M (+130.8%) 13.99% -0.005 pp 2.18% +1.110 pp USD2.99 -34.8% 9 qtrs
2 PERCEPTIVE ADVISORS LLC 12.59M +— (+0.0%) 24.56M +13.9M (+130.8%) 9.98% -0.003 pp 0.44% +0.130 pp USD8.06 -75.8% 19 qtrs
3 CERCANO MANAGEMENT LLC 7.17M +— (+0.0%) 13.99M +7.9M (+130.8%) 5.68% -0.002 pp 0.53% +0.297 pp USD1.80 +8.3% 13 qtrs
4 MADRONA VENTURE GROUP, LLC 6.02M +— (+0.0%) 11.74M +6.7M (+130.8%) 4.77% -0.002 pp 53.24% +16.474 pp USD10.10 -80.7% 19 qtrs
5 VANGUARD GROUP INC 2.60M +166.4K (+6.8%) 5.07M +3.0M (+146.6%) 2.06% +0.131 pp 0.00% +0.000 pp USD4.28 -54.4% 18 qtrs
6 COMPREHENSIVE FINANCIAL MANAGEMENT LLC 2.21M +— (+0.0%) 4.30M +2.4M (+130.8%) 1.75% -0.001 pp 0.13% +0.078 pp USD10.10 -80.7% 19 qtrs
7 AMAZON COM INC 1.46M +— (+0.0%) 2.84M +1.6M (+130.8%) 1.15% 0.000 pp 0.08% +0.031 pp USD10.10 -80.7% 19 qtrs
8 CLARIUS GROUP, LLC 1.21M +— (+0.0%) 2.36M +1.3M (+130.8%) 0.96% 0.000 pp 0.13% +0.074 pp USD2.63 -25.9% 18 qtrs
9 MILLENNIUM MANAGEMENT LLC 1.02M +52.4K (+5.4%) 1.99M +1.2M (+143.3%) 0.81% +0.041 pp 0.00% +0.001 pp USD0.83 +134.9% 5 qtrs
10 SENTINEL TRUST CO LBA 750.0K +750.0K (+100.0%) 1.46M +1.5M (+100.0%) 0.59% +0.594 pp 0.14% +0.144 pp USD1.95 +0.0% 16 qtrs
11 TIKVAH MANAGEMENT LLC 726.9K +— (+0.0%) 1.42M +803.3K (+130.8%) 0.58% 0.000 pp 0.38% +0.197 pp USD5.49 -64.5% 18 qtrs
12 ACADIAN ASSET MANAGEMENT LLC 612.0K +368.7K (+151.6%) 1.19M +984.0K (+484.7%) 0.48% +0.292 pp 0.00% +0.002 pp USD1.53 +27.5% 5 qtrs
13 GEODE CAPITAL MANAGEMENT, LLC 560.9K +7.3K (+1.3%) 1.09M +626.2K (+133.8%) 0.44% +0.006 pp 0.00% +0.000 pp USD4.33 -55.0% 19 qtrs
14 GOLDMAN SACHS GROUP INC 297.4K +179.7K (+152.7%) 580.0K +480.5K (+483.2%) 0.24% +0.142 pp 0.00% +0.000 pp USD1.98 -1.5% 18 qtrs
15 DIMENSIONAL FUND ADVISORS LP 285.4K -79.2K (-21.7%) 556.3K +248.5K (+80.7%) 0.23% -0.063 pp 0.00% +0.000 pp USD2.84 -31.3% 12 qtrs
16 RENAISSANCE TECHNOLOGIES LLC 259.9K -747.8K (-74.2%) 506.8K -344.6K (-40.5%) 0.21% -0.593 pp 0.00% 0.000 pp USD1.17 +66.7% 16 qtrs
17 ALYESKA INVESTMENT GROUP, L.P. 253.5K +— (+0.0%) 494.3K +280.1K (+130.8%) 0.20% 0.000 pp 0.00% +0.001 pp USD10.10 -80.7% 19 qtrs
18 JANE STREET GROUP, LLC 206.8K +58.6K (+39.6%) 403.3K +278.1K (+222.1%) 0.16% +0.046 pp 0.00% +0.000 pp USD1.30 +50.0% 12 qtrs
19 STATE STREET CORP 201.3K +22.5K (+12.6%) 392.4K +241.4K (+159.8%) 0.16% +0.018 pp 0.00% +0.000 pp USD3.35 -41.8% 18 qtrs
20 HILLMAN CO 200.0K +— (+0.0%) 390.0K +221.0K (+130.8%) 0.16% 0.000 pp 0.14% +0.083 pp USD10.10 -80.7% 19 qtrs
21 BLACKROCK, INC. 189.4K -12.0K (-6.0%) 369.4K +199.2K (+117.0%) 0.15% -0.010 pp 0.00% +0.000 pp USD2.85 -31.6% 6 qtrs
22 CREWE ADVISORS LLC 136.1K +— (+0.0%) 265.3K +150.4K (+130.8%) 0.11% +0.000 pp 0.02% +0.013 pp USD0.84 +132.1% 2 qtrs
23 BRIDGEWAY CAPITAL MANAGEMENT, LLC 130.0K +5.0K (+4.0%) 253.5K +147.9K (+140.0%) 0.10% +0.004 pp 0.01% +0.003 pp USD0.82 +137.8% 4 qtrs
24 GSA CAPITAL PARTNERS LLP 124.1K -135.2K (-52.1%) 242.0K +23.0K (+10.5%) 0.10% -0.107 pp 0.02% +0.003 pp USD0.77 +153.2% 4 qtrs
25 QUBE RESEARCH & TECHNOLOGIES LTD 123.1K +71.5K (+138.3%) 240.1K +196.4K (+450.0%) 0.10% +0.057 pp 0.00% +0.000 pp USD1.44 +35.4% 3 qtrs
26 MARSHALL WACE, LLP 117.1K +117.1K (+100.0%) 228.3K +228.3K (+100.0%) 0.09% +0.093 pp 0.00% +0.000 pp USD1.95 +0.0% 1 qtrs NEW
27 CI PRIVATE WEALTH, LLC 114.8K -204.4K (-64.0%) 223.8K -45.8K (-17.0%) 0.09% -0.162 pp 0.00% 0.000 pp USD0.89 +119.1% 7 qtrs
28 NORTHERN TRUST CORP 107.0K -10.8K (-9.2%) 208.7K +109.1K (+109.6%) 0.08% -0.009 pp 0.00% +0.000 pp USD3.58 -45.5% 18 qtrs
29 OMERS ADMINISTRATION CORP 104.8K +104.8K (+100.0%) 204.3K +204.3K (+100.0%) 0.08% +0.083 pp 0.00% +0.002 pp USD1.95 +0.0% 1 qtrs NEW
30 CITIGROUP INC 61.7K +60.8K (+6,881.0%) 120.3K +119.6K (+16,009.5%) 0.05% +0.048 pp 0.00% +0.000 pp USD1.96 -0.5% 19 qtrs
31 POINT72 ASSET MANAGEMENT, L.P. 60.8K +60.8K (+100.0%) 118.6K +118.6K (+100.0%) 0.05% +0.048 pp 0.00% +0.000 pp USD1.95 +0.0% 1 qtrs NEW
32 HSBC HOLDINGS PLC 49.4K -149.0 (-0.3%) 97.9K +57.8K (+143.9%) 0.04% 0.000 pp 0.00% +0.000 pp USD2.64 -26.1% 17 qtrs
33 BARCLAYS PLC 48.3K -57.9K (-54.6%) 94.1K -208.5K (-68.9%) 0.04% -0.046 pp 0.00% 0.000 pp USD1.95 +0.0% 16 qtrs
34 FAYEZ SAROFIM & CO 45.0K +— (+0.0%) 87.8K +49.7K (+130.8%) 0.04% +0.000 pp 0.00% +0.000 pp USD0.86 +126.7% 4 qtrs
35 ASHTON THOMAS PRIVATE WEALTH, LLC 45.0K +— (+0.0%) 87.8K +49.7K (+130.8%) 0.04% +0.000 pp 0.00% +0.001 pp USD0.84 +132.1% 2 qtrs
36 CAPROCK GROUP, LLC 44.1K +27.0K (+158.0%) 86.0K +74.4K (+639.8%) 0.03% +0.021 pp 0.00% +0.002 pp USD1.52 +28.3% 2 qtrs
37 SUSQUEHANNA INTERNATIONAL GROUP, LLP 42.9K +42.9K (+100.0%) 83.7K +83.7K (+100.0%) 0.03% +0.034 pp 0.00% +0.000 pp USD1.95 +0.0% 5 qtrs
38 PALUMBO WEALTH MANAGEMENT LLC 41.1K -984.0 (-2.3%) 80.2K +44.6K (+125.4%) 0.03% -0.001 pp 0.02% +0.008 pp USD1.71 +14.0% 7 qtrs
39 LIGHTHOUSE INVESTMENT PARTNERS, LLC 40.2K +40.2K (+100.0%) 78.4K +78.4K (+100.0%) 0.03% +0.032 pp 0.00% +0.002 pp USD1.95 +0.0% 1 qtrs NEW
40 MORGAN STANLEY 38.6K +12.9K (+50.0%) 75.2K +53.5K (+246.1%) 0.03% +0.010 pp 0.00% +0.000 pp USD2.47 -21.1% 19 qtrs
41 PRESIDIO CAPITAL MANAGEMENT, LLC 34.7K +— (+0.0%) 67.6K +38.3K (+130.8%) 0.03% +0.000 pp 0.02% +0.010 pp USD1.38 +41.3% 9 qtrs
42 CAPTRUST FINANCIAL ADVISORS 34.0K +34.0K (+100.0%) 66.3K +66.3K (+100.0%) 0.03% +0.027 pp 0.00% +0.000 pp USD1.95 +0.0% 1 qtrs NEW
43 XTX TOPCO LTD 33.6K -12.1K (-26.5%) 65.5K +26.9K (+69.6%) 0.03% -0.010 pp 0.00% 0.000 pp USD0.80 +143.8% 4 qtrs
44 BADGLEY PHELPS WEALTH MANAGERS, LLC 30.0K +— (+0.0%) 58.5K +33.2K (+130.8%) 0.02% +0.000 pp 0.00% +0.001 pp USD2.27 -14.1% 7 qtrs
45 BNP PARIBAS ARBITRAGE, SNC 27.7K +26.2K (+1,791.5%) 54.0K +52.8K (+4,264.8%) 0.02% +0.021 pp 0.00% +0.000 pp USD1.94 +0.5% 5 qtrs
46 CALLAN FAMILY OFFICE, LLC 26.0K +11.1K (+75.1%) 50.6K +38.1K (+304.2%) 0.02% +0.009 pp 0.00% +0.001 pp USD1.25 +56.0% 3 qtrs
47 VIRTU FINANCIAL LLC 23.5K +3.8K (+19.6%) 46.0K +29.0K (+170.6%) 0.02% +0.003 pp 0.00% +0.001 pp USD1.03 +89.3% 2 qtrs
48 BANK OF AMERICA CORP /DE/ 20.2K +19.4K (+2,380.6%) 39.3K +38.6K (+5,632.7%) 0.02% +0.015 pp 0.00% +0.000 pp USD1.97 -1.0% 19 qtrs
49 HUDSON BAY CAPITAL MANAGEMENT LP 19.1K +19.1K (+100.0%) 37.2K +37.2K (+100.0%) 0.02% +0.015 pp 0.00% +0.000 pp USD1.95 +0.0% 1 qtrs NEW
50 GARDE CAPITAL, INC. 18.0K +18.0K (+100.0%) 35.1K +35.1K (+100.0%) 0.01% +0.014 pp 0.00% +0.002 pp USD1.95 +0.0% 1 qtrs NEW
51 TWO SIGMA SECURITIES, LLC 16.2K +16.2K (+100.0%) 31.7K +31.7K (+100.0%) 0.01% +0.013 pp 0.00% +0.004 pp USD1.95 +0.0% 1 qtrs NEW
52 FNY INVESTMENT ADVISERS, LLC 14.0K +— (+0.0%) 27.0K +16.0K (+145.5%) 0.01% +0.000 pp 0.01% +0.004 pp USD1.00 +95.0% 5 qtrs
53 VANGUARD CAPITAL WEALTH ADVISORS 13.0K -500.0 (-3.7%) 25.4K +13.9K (+122.3%) 0.01% 0.000 pp 0.02% +0.011 pp USD3.48 -44.0% 17 qtrs
54 SQUAREPOINT OPS LLC 11.3K -120.5K (-91.4%) 22.1K -89.3K (-80.2%) 0.01% -0.096 pp 0.00% 0.000 pp USD0.93 +109.7% 5 qtrs
55 UBS GROUP AG 5.2K +4.7K (+998.5%) 10.1K +9.7K (+2,436.0%) 0.00% +0.004 pp 0.00% +0.000 pp USD1.99 -2.0% 13 qtrs
56 ROCKEFELLER CAPITAL MANAGEMENT L.P. 5.0K +— (+0.0%) 9.8K +5.5K (+130.8%) 0.00% +0.000 pp 0.00% +0.000 pp USD0.84 +132.1% 2 qtrs
57 GROUP ONE TRADING, L.P. 3.9K +3.9K (+100.0%) 7.6K +7.6K (+100.0%) 0.00% +0.003 pp 0.00% +0.000 pp USD1.95 +0.0% 1 qtrs NEW
58 FMR LLC 3.5K -5.2K (-59.7%) 6.8K -519.0 (-7.1%) 0.00% -0.004 pp 0.00% +0.000 pp USD1.23 +58.5% 14 qtrs
59 ROYAL BANK OF CANADA 3.3K +1.5K (+79.7%) 6.0K +5.0K (+500.0%) 0.00% +0.001 pp 0.00% +0.000 pp USD2.05 -4.9% 16 qtrs
60 TD WATERHOUSE CANADA INC. 1.0K +— (+0.0%) 1.9K +1.1K (+132.5%) 0.00% +0.000 pp 0.00% +0.000 pp USD5.18 -62.4% 17 qtrs
61 ADVISOR GROUP HOLDINGS, INC. 715.00 +— (+0.0%) 1.4K +809.0 (+138.3%) 0.00% +0.000 pp 0.00% +0.000 pp USD2.77 -29.6% 19 qtrs
62 WELLS FARGO & COMPANY/MN 560.00 +— (+0.0%) 1.1K +619.0 (+130.9%) 0.00% +0.000 pp 0.00% +0.000 pp USD2.89 -32.5% 19 qtrs
63 YOUR ADVOCATES LTD., LLP 150.00 +— (+0.0%) 293.00 +167.0 (+132.5%) 0.00% +0.000 pp 0.00% +0.000 pp USD1.80 +8.3% 13 qtrs
64 EVERSOURCE WEALTH ADVISORS, LLC 49.00 -180.0 (-78.6%) 96.00 -97.0 (-50.3%) 0.00% 0.000 pp 0.00% +0.000 pp USD0.98 +99.0% 5 qtrs
65 OPTIVER HOLDING B.V. 40.00 +— (+0.0%) 78.00 +44.0 (+129.4%) 0.00% +0.000 pp 0.00% +0.000 pp USD0.83 +134.9% 2 qtrs
66 TOWER RESEARCH CAPITAL LLC (TRC) 5.00 -5.6K (-99.9%) 10.00 -4.7K (-99.8%) 0.00% -0.004 pp 0.00% 0.000 pp USD1.20 +62.5% 18 qtrs
67 TRUE WEALTH DESIGN, LLC -17.0 (-100.0%) -15.0 (-100.0%) 0.00% +0.000 pp 0.00% +0.000 pp USD 4 qtrs SOLD
68 CITADEL ADVISORS LLC -254.2K (-100.0%) -214.7K (-100.0%) 0.00% -0.201 pp 0.00% +0.000 pp USD 11 qtrs SOLD
69 SRS CAPITAL ADVISORS, INC. -148.0 (-100.0%) -125.0 (-100.0%) 0.00% 0.000 pp 0.00% +0.000 pp USD 2 qtrs SOLD
70 JACOBS LEVY EQUITY MANAGEMENT, INC -301.0K (-100.0%) -254.3K (-100.0%) 0.00% -0.239 pp 0.00% -0.001 pp USD 4 qtrs SOLD
71 JPMORGAN CHASE & CO -2.1K (-100.0%) -1.8K (-100.0%) 0.00% -0.002 pp 0.00% +0.000 pp USD 17 qtrs SOLD
72 -350.0 (-100.0%) -296.0 (-100.0%) 0.00% 0.000 pp 0.00% 0.000 pp USD 5 qtrs SOLD
Ownership breakdown by holder

ETF Ownership

Top ETFs holding this stock Held by 40 ETFs in our universe
# ETF Weight Est. AUM exposure TER
1 iShares Micro-Cap ETF IWC 0.02% 314.8K 0.60%
2 Invesco Russell 2000 Dynamic Multifactor ETF OMFS 0.01% 17.4K 0.39%
3 iShares Russell 2000 Value ETF IWN 0.01% 723.9K 0.24%
4 Avantis U.S. Small Cap Equity ETF AVSC 0.00% 101.3K 0.25%
5 Invesco Russell 2000 UCITS ETF RTYS.L 0.00% 9.6K 0.25%
6 Global X - Russell 2000 ETF RSSL 0.00% 43.9K 0.08%
7 Xtrackers Russell 2000 UCITS ETF 1C XRSU.L 0.00% 80.8K 0.30%
8 iShares Russell 2000 BuyWrite ETF IWMW 0.00% 1.4K 0.39%
9 iShares Russell 2000 ETF IWM 0.00% 2.07M 0.19%
10 iShares U.S. Small Cap Index ETF (CAD-Hedged) XSU.TO 0.00% 13.5K 0.36%

Insider Activity

Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
8
Sells
0
Shares acquired
1.76M
Shares disposed
Cash buys
1.00
Cash sales
Net activity
+1,755,000
Insider buys vs sells (history) From To
Recent insider transactions From To
Date Person Role Transaction A/D Security Shares Price Value Owned after D/I Filing
2026-03-04 Patel Sujal M Director / Officer / 10% Owner P-Purchase A Common Stock 25,000 2.61 65.2K 10,366,721 D
2026-03-02 Weld Gwen E Officer A-Award A Stock Option (Right to Buy) 160,000 2.32 371.2K 160,000 D
2026-03-02 Suzuki Kentaro Officer A-Award A Stock Option (Right to Buy) 160,000 2.32 371.2K 160,000 D
2026-03-02 Sankar Subramanian Officer A-Award A Stock Option (Right to Buy) 160,000 2.32 371.2K 160,000 D
2026-03-02 Patel Sujal M Director / Officer / 10% Owner A-Award A Stock Option (Right to Buy) 650,000 2.32 1.51M 650,000 D
2026-03-02 Murphy Matthew B. Officer A-Award A Stock Option (Right to Buy) 160,000 2.32 371.2K 160,000 D
2026-03-02 Mowry Anna Officer A-Award A Stock Option (Right to Buy) 160,000 2.32 371.2K 160,000 D
2026-03-02 Mallick Parag Director / Officer / 10% Owner A-Award A Stock Option (Right to Buy) 280,000 2.32 649.6K 280,000 D
2025-11-06 Suzuki Kentaro Officer P-Purchase A Common Stock 4,000 1.49 6.0K 4,000 D
2025-09-08 Patel Sujal M Director / Officer / 10% Owner P-Purchase A Common Stock 83,500 0.68 57.0K 10,341,721 D
2025-09-05 Patel Sujal M Director / Officer / 10% Owner P-Purchase A Common Stock 116,500 0.67 78.5K 10,258,221 D
2025-09-04 Murphy Matthew B. Officer P-Purchase A Common Stock 20,000 0.64 12.9K 74,140 I
2025-06-23 Posard Matthew L. Director A-Award A Stock Option (Right to Buy) 45,000 0.70 31.3K 45,000 D
2025-06-23 NAZEM FARZAD Director A-Award A Stock Option (Right to Buy) 45,000 0.70 31.3K 45,000 D
2025-06-23 McIlwain Matthew S Director A-Award A Stock Option (Right to Buy) 45,000 0.70 31.3K 45,000 D
2025-06-23 Epperly Melissa B, Director A-Award A Stock Option (Right to Buy) 45,000 0.70 31.3K 45,000 D
2025-06-23 Akinsanya Karen Director A-Award A Stock Option (Right to Buy) 45,000 0.70 31.3K 45,000 D
2025-05-29 Mowry Anna Officer P-Purchase A Common Stock 15,000 0.77 11.5K 83,000 D
2025-05-12 Mallick Parag Director / Officer / 10% Owner P-Purchase A Common Stock 1,500 0.73 1.1K 20,493,392 D
2025-05-08 Mallick Parag Director / Officer / 10% Owner P-Purchase A Common Stock 12,000 0.73 8.8K 20,491,892 D
2025-03-20 Patel Sujal M Director / Officer / 10% Owner P-Purchase A Common Stock 23,933 1.00 23.9K 10,141,721 D
2025-03-19 Patel Sujal M Director / Officer / 10% Owner P-Purchase A Common Stock 53,300 0.99 53.0K 10,117,788 D
2025-03-03 Weld Gwen E Officer A-Award A Stock Option (Right to Buy) 160,000 1.24 198.4K 160,000 D
2025-03-03 Suzuki Kentaro Officer A-Award A Stock Option (Right to Buy) 50,000 1.24 62.0K 50,000 D
2025-03-03 Sankar Subramanian Officer A-Award A Stock Option (Right to Buy) 160,000 1.24 198.4K 160,000 D
2025-03-03 Patel Sujal M Director / Officer / 10% Owner A-Award A Stock Option (Right to Buy) 650,000 1.24 806.0K 650,000 D
2025-03-03 Nelson Nicholas A. Officer A-Award A Stock Option (Right to Buy) 160,000 1.24 198.4K 160,000 D
2025-03-03 Murphy Matthew B. Officer A-Award A Stock Option (Right to Buy) 160,000 1.24 198.4K 160,000 D
2025-03-03 Mowry Anna Officer A-Award A Stock Option (Right to Buy) 160,000 1.24 198.4K 160,000 D
2025-03-03 Mallick Parag Director / Officer / 10% Owner A-Award A Stock Option (Right to Buy) 280,000 1.24 347.2K 280,000 D
2024-09-23 Godwin Mary E. Officer M-Exempt D Stock Option (Right to Buy) 47,031 0.46 21.6K 353,337 D
2024-09-17 Godwin Mary E. Officer M-Exempt D Stock Option (Right to Buy) 35,000 0.46 16.1K 400,368
2024-09-16 Suzuki Kentaro Officer 0 0.00 0
2024-06-14 Posard Matthew L. Director A-Award A Stock Option (Right to Buy) 45,000 2.56 115.2K 45,000
2024-06-14 Pande Vijay Satyanand Director A-Award A Stock Option (Right to Buy) 45,000 2.56 115.2K 45,000
2024-06-14 PERCEPTIVE ADVISORS LLC Director / 10% Owner A-Award A Stock Option (Right to Buy) 45,000 2.56 115.2K 45,000
2024-06-14 NAZEM FARZAD Director A-Award A Stock Option (Right to Buy) 45,000 2.56 115.2K 45,000
2024-06-14 McIlwain Matthew S Director A-Award A Stock Option (Right to Buy) 45,000 2.56 115.2K 45,000
2024-06-14 Epperly Melissa B, Director A-Award A Stock Option (Right to Buy) 45,000 2.56 115.2K 45,000
2024-06-14 Akinsanya Karen Director A-Award A Stock Option (Right to Buy) 45,000 2.56 115.2K 45,000
2024-06-14 ALTMAN MICHAEL SETH Director A-Award A Stock Option (Right to Buy) 45,000 2.56 115.2K 45,000
2024-03-11 Patel Sujal M Director / Officer / 10% Owner P-Purchase A Common Stock 12,044 2.84 34.2K 10,064,488
2024-03-08 Patel Sujal M Director / Officer / 10% Owner P-Purchase A Common Stock 2,430 2.99 7.3K 10,052,444
2024-03-07 Patel Sujal M Director / Officer / 10% Owner P-Purchase A Common Stock 18,854 2.89 54.4K 10,050,014
2024-03-06 Patel Sujal M Director / Officer / 10% Owner P-Purchase A Common Stock 9,267 2.70 25.0K 10,031,160
2024-03-05 Patel Sujal M Director / Officer / 10% Owner P-Purchase A Common Stock 7,405 2.65 19.6K 10,021,893
2024-03-01 Weld Gwen E Officer A-Award A Stock Option (Right to Buy) 160,000 2.72 435.2K 160,000
2024-03-01 Sankar Subramanian Officer A-Award A Stock Option (Right to Buy) 160,000 2.72 435.2K 160,000
2024-03-01 Patel Sujal M Director / Officer / 10% Owner A-Award A Stock Option (Right to Buy) 650,000 2.72 1.77M 650,000
2024-03-01 Nelson Nicholas A. Officer A-Award A Stock Option (Right to Buy) 160,000 2.72 435.2K 160,000
2024-03-01 Murphy Matthew B. Officer A-Award A Stock Option (Right to Buy) 160,000 2.72 435.2K 160,000
2024-03-01 Mowry Anna Officer A-Award A Stock Option (Right to Buy) 160,000 2.72 435.2K 160,000
2024-03-01 Mallick Parag Director / Officer / 10% Owner A-Award A Stock Option (Right to Buy) 280,000 2.72 761.6K 280,000
2024-03-01 Godwin Mary E. Officer A-Award A Stock Option (Right to Buy) 160,000 2.72 435.2K 160,000
2023-06-15 Posard Matthew L. Director A-Award A Stock Option (Right to Buy) 45,000 3.97 178.7K 45,000
2023-06-15 Pande Vijay Satyanand Director A-Award A Stock Option (Right to Buy) 45,000 3.97 178.7K 45,000
2023-06-15 PERCEPTIVE ADVISORS LLC Director A-Award A Stock Option (Right to Buy) 45,000 3.97 178.7K 45,000
2023-06-15 NAZEM FARZAD Director A-Award A Stock Option (Right to Buy) 45,000 3.97 178.7K 45,000
2023-06-15 McIlwain Matthew S Director A-Award A Stock Option (Right to Buy) 45,000 3.97 178.7K 45,000
2023-06-15 Epperly Melissa B, Director A-Award A Stock Option (Right to Buy) 45,000 3.97 178.7K 45,000
2023-06-15 Akinsanya Karen Director A-Award A Stock Option (Right to Buy) 45,000 3.97 178.7K 45,000
2023-06-15 ALTMAN MICHAEL SETH Director A-Award A Stock Option (Right to Buy) 45,000 3.97 178.7K 45,000
2023-02-27 Weld Gwen E Officer A-Award A Stock Option (Right to Buy) 160,000 2.00 320.0K 160,000
2023-02-27 Sankar Subramanian Officer A-Award A Stock Option (Right to Buy) 160,000 2.00 320.0K 160,000
2023-02-27 Patel Sujal M Director / Officer / 10% Owner A-Award A Stock Option (Right to Buy) 650,000 2.00 1.30M 650,000
2023-02-27 Nelson Nicholas A. Officer A-Award A Stock Option (Right to Buy) 160,000 2.00 320.0K 160,000
2023-02-27 Murphy Matthew B. Officer A-Award A Stock Option (Right to Buy) 160,000 2.00 320.0K 160,000
2023-02-27 Mowry Anna Officer A-Award A Stock Option (Right to Buy) 160,000 2.00 320.0K 160,000
2023-02-27 Mallick Parag Director / Officer / 10% Owner A-Award A Stock Option (Right to Buy) 280,000 2.00 560.0K 280,000
2023-02-27 Godwin Mary E. Officer A-Award A Stock Option (Right to Buy) 160,000 2.00 320.0K 160,000
2022-09-27 Sankar Subramanian Officer P-Purchase A Common Stock 5,000 2.03 10.1K 91,250
2022-09-26 Sankar Subramanian Officer P-Purchase A Common Stock 10,000 2.03 20.3K 86,250
2022-09-23 Weld Gwen E Officer P-Purchase A Common Stock 30,000 2.03 60.8K 30,000
2022-09-16 Sankar Subramanian Officer P-Purchase A Common Stock 35,000 2.16 75.4K 75,000
2022-09-15 Sankar Subramanian Officer P-Purchase A Common Stock 40,000 2.19 87.8K 40,000
2022-08-19 Mowry Anna Officer P-Purchase A Common Stock 17,500 2.30 40.2K 56,750
2022-08-12 Murphy Matthew B. Officer P-Purchase A Common Stock 2,500 2.85 7.1K 46,640
2022-08-05 Patel Sujal M Officer P-Purchase A Common Stock 41,654 2.92 121.6K 10,006,142
2022-08-03 Godwin Mary E. Officer A-Award A Stock Option (Right to Buy) 30,000 0.00 30,000
2022-07-01 Godwin Mary E. Officer D Stock Option (Right to Buy) 435,368 0.46 200.3K 0
2022-06-27 Mowry Anna Officer P-Purchase A Common Stock 5,500 2.75 15.1K 39,250
2022-06-15 Posard Matthew L. Director A-Award A Stock Option (Right to Buy) 86,467 2.70 233.5K 86,467
2022-06-15 Pande Vijay Satyanand Director A-Award A Stock Option (Right to Buy) 86,467 0.00 86,467
2022-06-15 PERCEPTIVE ADVISORS LLC Director / 10% Owner A-Award A Stock Option (Right to Buy) 86,467 2.70 233.5K 86,467
2022-06-15 NAZEM FARZAD Director A-Award A Stock Option (Right to Buy) 86,467 0.00 86,467
2022-06-15 McIlwain Matthew S Director A-Award A Stock Option (Right to Buy) 86,467 0.00 86,467
2022-06-15 Epperly Melissa B, Director A-Award A Stock Option (Right to Buy) 86,467 2.70 233.5K 86,467
2022-06-15 EDELMAN JOSEPH Director A-Award A Stock Option (Right to Buy) 86,467 0.00 86,467
2022-06-15 Akinsanya Karen Director A-Award A Stock Option (Right to Buy) 14,411 0.00 14,411
2022-06-15 ALTMAN MICHAEL SETH Director A-Award A Stock Option (Right to Buy) 86,467 0.00 86,467
2022-05-12 Murphy Matthew B. Officer A-Award A Common Stock 10,000 3.28 32.8K 44,140
2022-05-09 Patel Sujal M Officer P-Purchase A Common Stock 50,000 3.96 198.0K 9,964,488
2022-05-04 Weld Gwen E Officer A-Award A Stock Option (Right to Buy) 375,000 0.00 375,000
2022-05-04 Nelson Nicholas A. Officer A-Award A Stock Option (Right to Buy) 54,422 0.00 54,422
2022-04-11 Weld Gwen E Officer D Stock Option (Right to Buy) 4,535 1.14 5.2K 0
2022-03-30 Akinsanya Karen Director 0 0.00 0
2022-03-03 Patel Sujal M Officer P-Purchase A Common Stock 50,000 3.60 179.9K 9,914,388
2022-02-25 Sankar Subramanian Officer A-Award A Stock Option (Right to Buy) 140,000 3.78 529.2K 140,000
2022-02-25 Patel Sujal M Director / Officer / 10% Owner A-Award A Stock Option (Right to Buy) 400,000 3.78 1.51M 400,000
2022-02-25 Nelson Nicholas A. Officer A-Award A Stock Option (Right to Buy) 140,000 3.78 529.2K 140,000
2022-02-25 Murphy Matthew B. Officer A-Award A Stock Option (Right to Buy) 140,000 3.78 529.2K 140,000
2022-02-25 Mowry Anna Officer A-Award A Stock Option (Right to Buy) 280,000 3.78 1.06M 280,000
2022-02-25 Mallick Parag Director / Officer / 10% Owner A-Award A Stock Option (Right to Buy) 280,000 3.78 1.06M 280,000
2021-12-21 Mallick Parag Director / Officer / 10% Owner G-Gift D Common Stock 210,000 0.00 20,479,892
2021-12-08 PERCEPTIVE ADVISORS LLC Director P-Purchase A Common Stock 200,000 5.36 1.07M 9,111,151
2021-12-01 Posard Matthew L. Director P-Purchase A Common Stock 10,000 4.45 44.5K 50,000
2021-12-01 Patel Sujal M Director / Officer / 10% Owner P-Purchase A Common Stock 88,022 4.73 416.4K 9,864,388
2021-11-30 Posard Matthew L. Director P-Purchase A Common Stock 20,000 4.57 91.4K 20,000
2021-11-30 Patel Sujal M Director / Officer / 10% Owner P-Purchase A Common Stock 161,978 4.72 764.8K 9,776,366
2021-11-24 Mowry Anna Officer P-Purchase A Common Stock 15,000 4.58 68.6K 32,500
2021-11-15 McIlwain Matthew S Director P-Purchase A Common Stock 100,000 5.30 529.9K 459,075
2021-08-26 McIlwain Matthew S Director P-Purchase A Common Stock 11,709 7.71 90.3K 359,075
2021-08-25 McIlwain Matthew S Director P-Purchase A Common Stock 11,693 7.74 90.5K 347,366
2021-08-24 McIlwain Matthew S Director P-Purchase A Common Stock 13,568 7.68 104.3K 335,673
2021-08-13 Murphy Matthew B. Officer P-Purchase A Common Stock 5,000 7.56 37.8K 34,140
2021-08-12 Mowry Anna Officer P-Purchase A Common Stock 17,500 7.71 134.9K 17,500
2021-06-14 Murphy Matthew B. Officer A-Award A Stock Option (Right to Buy) 326,526 10.10 3.30M 326,526
2021-06-09 Sankar Subramanian Officer D Stock Option (Right to Buy) 725,614 1.14 827.2K 0
2021-06-09 Posard Matthew L. Director I Common Stock 0 0.00 100,000
2021-06-09 Patel Sujal M Director / Officer / 10% Owner I Common Stock 0 0.00 1,814,035
2021-06-09 Pande Vijay Satyanand Director I Common Stock 0 0.00 16,298,006
2021-06-09 PERCEPTIVE ADVISORS LLC J-Other A Common Stock 2,914,113 0.00 8,911,151
2021-06-09 Nelson Nicholas A. Officer D Stock Option (Right to Buy) 816,315 1.14 930.6K 0
2021-06-09 NAZEM FARZAD Director I Common Stock 0 0.00 1,888,146
2021-06-09 Murphy Matthew B. Officer I Common Stock 0 0.00 29,140
2021-06-09 Mowry Anna Officer D Stock Option (Right to Buy) 435,368 1.14 496.3K 0
2021-06-09 McIlwain Matthew S Director D Stock Option (Right to Buy) 36,280 10.00 362.8K 0
2021-06-09 Mallick Parag Director / Officer / 10% Owner D Stock Option (Right to Buy) 464,019 10.00 4.64M 0
2021-06-09 Epperly Melissa B, Director D Stock Option (Right to Buy) 72,561 10.00 725.6K 0
2021-06-09 ALTMAN MICHAEL SETH Director C-Conversion A Common Stock 3,647,500 0.00 364.75 3,647,500
2021-06-09 AH Equity Partners Bio II, L.L.C. 10% Owner I Common Stock 0 0.00 1,355,911
2021-06-03 PERCEPTIVE ADVISORS LLC Director P-Purchase A Class A Ordinary Shares 330,050 10.05 3.32M 489,975
2021-05-24 PERCEPTIVE ADVISORS LLC P-Purchase A Common Stock 7,063 10.05 71.0K 497,038
2021-05-20 PERCEPTIVE ADVISORS LLC Director 0 0.00 0
2020-08-11 Stone Adam Leo Director / Officer / 10% Owner J-Other A Class A ordinary shares 499,000 10.00 4.99M 499,000
2020-08-11 ARYA Sciences Holdings III 10% Owner J-Other A Class A ordinary shares 499,000 10.00 4.99M 499,000
2020-08-11 ALTMAN MICHAEL SETH Director / Officer / 10% Owner J-Other A Class A ordinary shares 499,000 10.00 4.99M 499,000
2020-08-06 Wider Todd Director D Class B ordinary shares 30,000 0.00 0
2020-08-06 Stone Adam Leo Director / Officer / 10% Owner I Class B ordinary shares 3,647,500 0.00 0
2020-08-06 Poukalov Konstantin 0 0.00 0
2020-08-06 Islam Saqib Director D Class B ordinary shares 30,000 0.00 0
2020-08-06 EDELMAN JOSEPH 0 0.00 0
2020-08-06 Campbell Bradley L Director D Class B ordinary shares 30,000 0.00 0
2020-08-06 ARYA Sciences Holdings III 10% Owner D Class B ordinary shares 3,647,500 0.00 0
2020-08-06 ALTMAN MICHAEL SETH Director / Officer / 10% Owner I Class B ordinary shares 3,647,500 0.00 0
2003-08-27 TISHMAN STEVEN Director D-Return D Employee Stock Option (Right to buy) 2,000 11.65 23.3K 0
2003-08-27 SANDERS HARVEY Director / Officer D-Return D Employee Stock Option (Right to buy) 177,000 7.46 1.32M 0
2003-08-27 ROSENZWEIG ISRAEL Director D-Return D Employee Stock Option (Right to buy) 8,000 11.28 90.2K 0
2003-08-27 MARINO WAYNE Officer D-Return D Common Stock 10,000 12.25 122.5K 0
2003-08-27 BANK ROBERT B Director D-Return D Employee Stock Option (Right to buy) 6,000 7.17 43.0K 0
2003-07-17 SANDERS HARVEY Director / Officer / 10% Owner M-Exempt D Stock Option (Right to Buy) 202,500 4.45 901.1K 0

Executive team

Top executives
Shares Outstanding
127.08M

Executive compensation

Executive compensation (annual)
# Year Executive Salary Bonus Stock award Option award Incentive Other Total % Stock-
based
Filing
1 2025 Sujal Patel President, Chief Executive Officer and Secretary 535.0K 655.0K 227.4K 1.2K 1.42M 46.17%
2 2025 Parag Mallick Chief Scientist 420.0K 282.1K 115.5K 817.6K 34.51%
3 2025 Anna Mowry Chief Financial Officer 440.0K 161.2K 110.0K 1.2K 712.4K 22.63%
4 2024 Sujal Patel President, Chief Executive Officer and Secretary 535.0K 1.43M 1.2K 1.96M 72.66%
5 2024 Kentaro Suzuki Chief Marketing Officer 123.4K 20.0K 894.4K 1.04M 86.18%
6 2024 Parag Mallick Chief Scientist 420.0K 613.9K 1.03M 59.38%
7 2024 Anna Mowry Chief Financial Officer 400.0K 350.8K 1.2K 752.0K 46.65%
8 2023 Sujal Patel President, Chief Executive Officer and Secretary 535.0K 1.07M 291.0K 1.2K 1.89M 56.30%
9 2023 Parag Mallick Chief Scientist 420.0K 459.0K 142.8K 1.02M 44.92%
10 2023 Anna Mowry Chief Financial Officer and Treasurer 386.0K 262.3K 132.0K 1.2K 781.5K 33.56%
11 2022 Gwen Weld Chief People Officer 245.5K 1.47M 60.7K 84.8K 1.87M 79.04%
12 2022 Sujal Patel President, Chief Executive Officer and Secretary 500.0K 1.26M 1.2K 1.76M 71.49%
13 2022 Anna Mowry Chief Financial Officer and Treasurer 364.0K 879.6K 102.4K 1.2K 1.35M 65.29%
14 2022 Parag Mallick Chief Scientist 400.0K 879.6K 1.28M 68.74%
15 2021 Sujal Patel President, Chief Executive Officer and Secretary 436.7K 5.95M 154.6K 60.7K 6.61M 90.13%
16 2021 Parag Mallick Chief Scientist 379.8K 3.50M 117.7K 4.00M 87.56%
17 2021 Matthew Murphy General Counsel 231.1K 2.48M 74.3K 250.00 2.79M 89.05%
18 2020 Sujal Patel President, Chief Executive Officer and Secretary 200.0K 50.0K 1.5K 251.5K 0.00%
CEO compensation breakdown

Proxy statements

Proxy statements (DEF 14A)
Filing date Form type Filing
2026-04-28 DEFA14A
2026-04-28 DEF 14A
2025-04-29 DEFA14A
2025-04-29 DEF 14A
2024-04-26 DEFA14A
2024-04-26 DEF 14A

Recent SEC filings

Recent SEC filings
Filing date Form type Filing
2026-04-28 DEFA14A
2026-04-28 DEF 14A
2026-04-28 ARS
2026-04-28 8-K
2026-04-28 10-Q
2026-03-04 SC 13D/A
2026-03-04 SC 13D/A
2026-03-04 4
2026-03-04 4
2026-03-04 4

Executive team

NameTitleCompensationGender
Sujal Patel Co-Founder, Chief Executive Officer, President, Secretary & Director 763.6K male
Anna Mowry Chief Financial Officer & Treasurer 551.2K female
Parag Mallick Co-Founder, Chief Scientist & Director 535.5K
Gwen E. Weld Chief People Officer 391.0K female
Matthew Murphy ESQ. General Counsel 382.6K male
Kentaro Suzuki Chief Marketing Officer 143.4K male
Subra Sankar Senior Vice President of Product Development 38.5K
Amber Faust Vice President of Global Sales female
ESG Rating
B+
BIOTECHNOLOGY
2026
E (Environmental)
50.0 / 56.3
Company / Sector avg.
S (Social)
60.2 / 62.4
Company / Sector avg.
G (Governance)
49.5 / 60.9
Company / Sector avg.
ESG Total
53.2 / 59.9
Company / Sector avg.
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend history

Earnings history

Earnings reports

Stock splits